tradingkey.logo
Search
Markets
Watchlist
News
Analysis
Tools
Stock Screener
English
繁体中文
ไทย
Tiếng việt
简体中文
Español
Português
Deutsch
한국어
日本語
tradingkey.logo
Search

Anika Therapeutics Inc

ANIK
Add to Watchlist
19.250USD
+1.180+6.53%
Close 07-31 16:00（ET）Quotes delayed by 15 min
257.12MMarket Cap
LossP/E TTM

Anika Therapeutics Inc

19.250
+1.180+6.53%
Overview
Financials
Discussions
Analysis
Company
Financial SummaryIncome StatementBalance SheetCash Flow Statement

Overview

Financials

Discussions

Analysis

Company

Financial SummaryIncome StatementBalance SheetCash Flow Statement

ANIK Financials

See Anika Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Anika Therapeutics Inc Earnings Date

Latest Release
Jul 29, 2026
EPS / Forecast
0.25/-0.08
Revenue / Forecast
32.61M/29.21M
See Upcoming Earnings >>
Period
FY2025 Earnings
Revenue(YoY)
112.82M
-5.91%
EPS(YoY)
-0.76
80.19%
Analyst Rating
STRONG BUY
2026/07/31
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q2
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
Financial Indicators
EPS
189.82%0.25
-9.63%-0.37
101.36%0.02
92.03%-0.16
-4560.88%-0.28
-10.98%-0.34
65.13%-1.50
-350.86%-2.03
96.82%-0.01
56.52%-0.31
-1181.08%-4.30
---0.45
---0.19
---0.71
---0.34
---0.68
----
----
----
----
Revenue
15.56%32.61M
13.16%29.61M
--30.61M
-28.22%27.82M
-32.69%28.22M
-9.83%26.17M
----
-6.54%38.75M
-5.37%41.92M
-23.47%29.02M
8.45%42.97M
2.98%41.47M
11.71%44.30M
3.35%37.92M
10.61%39.62M
1.84%40.26M
3.96%39.66M
7.00%36.69M
9.58%35.82M
24.74%39.54M
Net Profit
183.35%3.31M
-3.76%-5.06M
101.34%292.00K
92.22%-2.33M
-4411.36%-3.97M
-7.95%-4.87M
65.29%-21.86M
-354.96%-29.92M
96.79%-88.00K
56.39%-4.51M
-1183.62%-63.00M
-57.51%-6.58M
3.59%-2.74M
-252.88%-10.35M
15.28%-4.91M
-848.21%-4.17M
-143.53%-2.84M
-203.35%-2.93M
63.00%-5.79M
108.70%558.00K
Net Margin
161.62%10.15%
-12.88%-17.07%
--5.88%
85.22%-11.41%
-99.12%-16.47%
-124.42%-15.13%
----
-386.80%-77.20%
-33.67%-8.27%
75.30%-6.74%
----
---15.86%
---6.19%
---27.29%
---12.39%
---8.53%
----
----
----
----
Gross Margin
27.99%65.15%
14.35%64.15%
--62.65%
-10.06%56.02%
-23.68%50.90%
-14.19%56.10%
----
3.55%62.29%
1.97%66.69%
8.55%65.38%
----
--60.16%
--65.40%
--60.23%
--60.90%
--59.55%
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
--0.00%
----
----
----
----
Income Statement
Revenue
15.56%32.61M
13.16%29.61M
--30.61M
-28.22%27.82M
-32.69%28.22M
-9.83%26.17M
----
-6.54%38.75M
-5.37%41.92M
-23.47%29.02M
8.45%42.97M
2.98%41.47M
11.71%44.30M
3.35%37.92M
10.61%39.62M
1.84%40.26M
3.96%39.66M
7.00%36.69M
9.58%35.82M
24.74%39.54M
Operating profit
183.40%3.49M
12.89%-3.73M
-97.40%646.00K
-84.64%-3.23M
-1325.81%-4.18M
-125.00%-4.28M
0.60%24.85M
77.18%-1.75M
123.86%341.00K
77.53%-1.90M
470.51%24.70M
-32.36%-7.67M
57.73%-1.43M
-138.38%-8.47M
19.66%-6.67M
-169.67%-5.80M
24.36%-3.38M
0.22%-3.55M
-36.77%-8.30M
43.08%-2.15M
Net Profit
183.35%3.31M
-3.76%-5.06M
101.34%292.00K
92.22%-2.33M
-4411.36%-3.97M
-7.95%-4.87M
65.29%-21.86M
-354.96%-29.92M
96.79%-88.00K
56.39%-4.51M
-1183.62%-63.00M
-57.51%-6.58M
3.59%-2.74M
-252.88%-10.35M
15.28%-4.91M
-848.21%-4.17M
-143.53%-2.84M
-203.35%-2.93M
63.00%-5.79M
108.70%558.00K
Balance Sheet
Current assets
-0.13%99.19M
-8.73%93.56M
-9.06%103.36M
-25.36%101.59M
-35.92%99.32M
-35.51%102.51M
-30.41%113.65M
-13.19%136.11M
1.84%155.00M
-0.85%158.96M
-3.68%163.31M
-6.55%156.78M
-9.33%152.20M
-3.02%160.33M
0.60%169.55M
1.19%167.76M
-5.57%167.86M
-4.70%165.32M
-4.99%168.53M
-17.88%165.78M
Total current liabilities
37.72%22.15M
17.12%20.97M
-6.00%21.91M
-25.12%19.09M
-38.44%16.08M
-37.10%17.90M
-24.96%23.31M
-9.16%25.49M
11.36%26.12M
-0.81%28.46M
11.27%31.06M
6.50%28.06M
-20.30%23.46M
6.30%28.69M
-6.31%27.91M
-8.41%26.35M
-28.85%29.43M
-42.54%26.99M
-19.18%29.80M
-7.60%28.77M
Total assets
-2.24%183.47M
-5.89%179.39M
-6.15%190.27M
-18.14%189.44M
-28.54%187.68M
-27.73%190.60M
-25.09%202.74M
-29.48%231.41M
-20.14%262.65M
-22.22%263.74M
-22.48%270.63M
-5.63%328.16M
-7.13%328.88M
-0.92%339.07M
0.46%349.13M
-1.47%347.75M
-2.48%354.12M
-5.52%342.24M
-4.94%347.54M
-15.23%352.93M
Total liabilities
15.45%46.19M
7.77%45.49M
-3.99%46.80M
-17.29%42.63M
-23.52%40.01M
-23.55%42.21M
-16.48%48.75M
-10.63%51.54M
-4.65%52.32M
-10.21%55.21M
-8.18%58.37M
-8.18%57.67M
-19.28%54.87M
8.92%61.49M
5.15%63.56M
-0.10%62.81M
-10.95%67.97M
-34.05%56.45M
-35.14%60.45M
-52.33%62.87M
Total equity
-7.04%137.28M
-9.77%133.90M
-6.83%143.47M
-18.38%146.81M
-29.79%147.67M
-28.84%148.40M
-27.45%153.99M
-33.50%179.86M
-23.24%210.34M
-24.88%208.54M
-25.67%212.26M
-5.07%270.49M
-4.24%274.01M
-2.87%277.59M
-0.53%285.56M
-1.77%284.94M
-0.23%286.15M
3.30%285.79M
5.39%287.08M
1.97%290.06M
Cash Flow Statement
Net operating income
-261.90%-684.00K
-3627.69%-4.85M
193.11%4.64M
36.96%6.87M
82.32%-189.00K
-3.17%-130.00K
-56.51%1.58M
-22.65%5.02M
87.11%-1.07M
96.52%-126.00K
656.34%3.64M
139.39%6.49M
-368.56%-8.29M
-93.58%-3.62M
-89.24%481.00K
31.38%2.71M
-28.09%3.09M
23.12%-1.87M
72.86%4.47M
-64.84%2.06M
Net investment
-137.48%-1.28M
-174.10%-1.24M
115.15%198.00K
4.63%-1.73M
84.16%-539.00K
192.48%1.67M
28.97%-1.31M
-145.07%-1.82M
-133.56%-3.40M
-30.17%-1.81M
27.24%-1.84M
56.18%-741.00K
24.90%-1.46M
-4.75%-1.39M
-103.95%-2.53M
-30.58%-1.69M
16.27%-1.94M
-176.47%-1.33M
-107.38%-1.24M
-119.25%-1.29M
Net financing
-491.62%-701.00K
-90.27%-10.35M
1.40%-5.28M
99.67%-13.00K
116.11%179.00K
-139.24%-5.44M
-1665.50%-5.35M
-3528.18%-3.99M
77.52%-1.11M
-40.92%-2.27M
-48.73%342.00K
97.61%-110.00K
-10645.65%-4.94M
-87.12%-1.61M
1011.67%667.00K
33.96%-4.61M
-107.74%-46.00K
-91.13%-862.00K
100.21%60.00K
72.27%-6.98M

FAQs

What is the total revenue of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its total revenue reached 112.82M, with a year-on-year change of 119.91M.

What are the current assets of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its current assets were 103.36M, with a year-on-year change of -9.06.

What are the total assets of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its total assets of Anika Therapeutics Inc were 190.27M, with a year-on-year change of -6.15.

What are the total liabilities of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its total liabilities of Anika Therapeutics Inc were 46.80M, with a year-on-year change of -3.99.

What is the total equity of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its total equity of Anika Therapeutics Inc was 143.47M, with a year-on-year change of -6.83.

What is the net operating income of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its net operating income of Anika Therapeutics Inc was -11.05M, with a year-on-year change of -378.40.

What is the net investment of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its net investment of Anika Therapeutics Inc was -401.00K, with a year-on-year change of 95.19.

What is the net financing of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its net financing of Anika Therapeutics Inc was -10.55M, with a year-on-year change of 17.11.

What is the Earnings Per Share (EPS) of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -0.76, with a year-on-year change of 80.19.

What is the net income of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its net income was -10.88M, with a year-on-year change of 80.70.

What is the net margin of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its net profit margin was -8.85, with a year-on-year change of -20.14.

What is the gross margin of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its gross margin was 56.56, with a year-on-year change of -11.47.

What is the Return on Equity (ROE) of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its Return on Equity (ROE) was -6.71, with a year-on-year change of -39.18.

What is the Return on Assets (ROA) of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -5.08, with a year-on-year change of -36.15.

What is the operating profit of Anika Therapeutics Inc?

According to Anika Therapeutics Inc's FY2025 earnings report, its operating profit was -11.05M, with a year-on-year change of -378.40.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.
General Terms of Use
Privacy Policy
Cookie Policy